EONE DIAGNOMICS GENOME CENTER CO., LTD. Funds and ETFs Eone Diagnomics Genome Center Co., Ltd.
Equities
A245620
KR7245620000
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 415 KRW | -5.25% |
|
-.--% | -0.72% |
Eone Diagnomics Genome Center Co., Ltd. is a Korea-based company engaged in genetic analysis business. The Company is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.72% | 41.72M | |
| +16.03% | 70.45B | |
| +2.22% | 25.03B | |
| +7.11% | 8.29B | |
| -2.98% | 8.05B | |
| -20.55% | 7.97B | |
| +3.91% | 4.62B | |
| +17.12% | 4.25B | |
| -1.24% | 4.04B | |
| -3.44% | 3.86B |
- Stock Market
- Equities
- A245620 Stock
- Funds and ETFs Eone Diagnomics Genome Center Co., Ltd.
